Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2017 | Checkpoint blockade in patients with brain metastases

Dirk Schadendorf, MD from the West German Cancer Centre, University Hospital Essen, Germany discusses the future treatment opportunities due to the new findings presented at the American Society of Oncology (ASCO) 2017 Annual Meeting held in Chicago, ILASCO 2017. The main objective of ASCO is for experts to share information, to move towards the goal of curing cancer. Experts have presented data on the effect of checkpoint blockade in brain metastasis, and the response rates of these patients who otherwise may have an extremely poor prognosis.